A. Ahmad

Detection of BRCA1/2 mutations in breast cancer patients from Thailand and Pakistan

S. Sangrajrang, V. Gaborieau, O. Sinilnikova, 2012, Clinical genetics.

The Burden of Cancer, Government Strategic Policies, and Challenges in Pakistan: A Comprehensive Review

Sameh A. Korma, Aizhong Liu, M. Manzoor, 2022, Frontiers in Nutrition.

Endoxifen, a New Cornerstone of Breast Cancer Therapy: Demonstration of Safety, Tolerability, and Systemic Bioavailability in Healthy Human Subjects

S. Sheikh, I. Ahmad, S. Shahabuddin, 2010, Clinical pharmacology and therapeutics.

Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial

Prabhjot S. Mundi, S. Cremers, J. Sparano, 2018, Clinical and Translational Oncology.

Endoxifen, a New Treatment Option for Mania: A Double‐Blind, Active‐Controlled Trial Demonstrates the Antimanic Efficacy of Endoxifen

S. Sheikh, M. Reddy, P. Kale, 2016, Clinical and translational science.

Bioequivalence Study of Pegylated Doxorubicin Hydrochloride Liposome in Ovarian Cancer Patients: Physicochemical Characterization, Safety, Efficacy, and Pharmacokinetics of Pegylated Doxorubicin Hydrochloride Liposome and Doxil

Munir Ahmad, C. Satheesh, K. Choudhury, 2016 .

Crosstalk of Cyclin-dependent kinase inhibitor 1A (CDKN1A) gene polymorphism with p53 and CCND1 polymorphism in breast cancer.

A. Jawed, S. Dar, M. Wahid, 2021, European Review for Medical and Pharmacological Sciences.